Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Cassava Sciences (NASDAQ:SAVA) Shares Down 3.8% | news.google.com • |
Cassava Sciences stock gains on pact with ex-CEO (NASDAQ:SAVA) | news.google.com • |
Cassava Sciences (NASDAQ:SAVA) Trading Up 10.8% | news.google.com • |
(SAVA) Technical Pivots with Risk Controls | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-11-05 | 2024-09 | -1.37 | N/A | N/A | N/A |
2024-08-08 | 2024-06 | -0.44 | -1.28 | -0.84 | -190.91% |
2024-05-10 | 2024-03 | -0.51 | -1.41 | -0.9 | -176.47% |
2024-02-28 | 2023-12 | -0.4 | -0.5 | -0.1 | -25.00% |
2023-11-07 | 2023-09 | -0.9 | -0.61 | 0.29 | 32.22% |
2023-08-03 | 2023-06 | -0.58 | -0.63 | -0.05 | -8.62% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-07 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-07-05 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-05-10 | HC Wainwright & Co. | Upgrade | Buy | Buy |
2023-05-08 | HC Wainwright & Co. | Upgrade | Buy | |
2023-03-05 | HC Wainwright & Co. | Upgrade | Buy | |
2023-01-23 | HC Wainwright & Co. | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2018-10-02 | ARMISTICE CAPITAL L.L.C. | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Sale |
2023-05-23 | BARBIER REMI | Chief Executive Officer | 0.00 | Conversion of Exercise of derivative security |
2024-04-22 | BARRY RICHARD J | Director | 0.00 | Conversion of Exercise of derivative security |
2022-10-02 | FRIEDMANN NADAV | Officer and Director | 80.05K | Conversion of Exercise of derivative security |
2023-04-30 | GUSSIN ROBERT Z | Director | 10.62K | Conversion of Exercise of derivative security |
2024-04-17 | KUPIEC JAMES WILLIAM | Officer | 4.00K | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Blackrock Inc. | 2.75M | 67.35M | 6.54% |
2023-06-29 | Vanguard Group Inc | 2.25M | 55.16M | 5.36% |
2023-06-29 | State Street Corporation | 952.09K | 23.35M | 2.27% |
2023-06-29 | Geode Capital Management, LLC | 803.31K | 19.70M | 1.91% |
2023-06-29 | Gallacher Capital Management LLC | 583.29K | 14.30M | 1.39% |
2023-06-29 | Northern Trust Corporation | 370.64K | 9.09M | 0.88% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 1.23M | 30.21M | 2.94% |
2023-08-30 | iShares Russell 2000 ETF | 908.42K | 19.05M | 2.16% |
2023-06-29 | Vanguard Extended Market Index Fund | 542.35K | 13.30M | 1.29% |
2023-07-30 | Fidelity Small Cap Index Fund | 353.09K | 7.76M | 0.84% |
2023-08-30 | iShares Russell 2000 Growth ETF | 333.17K | 6.99M | 0.79% |
2023-05-30 | Fidelity Extended Market Index Fund | 202.34K | 4.60M | 0.48% |
Dividend | Date |
---|---|
0.75 | 2012-12-13 |
2 | 2010-12-13 |
Split | Date |
---|---|
1 : 7 | 2017-05-10 |
-
$SAVA - every time the stock goes red, indicates that shorts are going further out on a very skinny branch. Shorts are very skilled living in a space that has higher heart attack, high blood pressure, divorce and death rates. Stats on traders such as these shows they are risking everything to make a quick buck - steady as she goes, hold the line - dont sell a share.
-
$SAVA: Common sense reasoning says shorts are losing money every day they hold. Why will SAVA continue on an upward trend? Because losing money that you cant get back, isn’t smart. Shorts are fighting a losing battle. Over 1,100 shares, not selling one - Its all or nothing. The reasoning behind holding is facts, real scientific facts lean towards SAVA’s success as opposed to smack talk and pre supposed negative spins. Simple for longs that have been patiently holding…just hold till December. That’s it.
-
$SAVA - going to be interesting to see who controls the movement at days end…
-
$SAVA, really enjoying the stock movement today beginning with a -$1.00 dip, ascending in moderation to +$1.00+. It is what we have been seeing the past week or so - looks like shorts attempting to control the stock, but more bulls buying and pulling the price up. Shorts unable to get it below $20 as they have after warrant option expired. I still think next resistance is $26-$29…
-
$SAVA holding for P3 - nothing else matters - all or nothing.
-
$SAVA any volume and this flies!! Best reward to risk ratio on the market.
-
$SAVA I’m not selling
-
Unless ya’ll are getting shaken loose of your shares, this price will have to break higher fast before closing. $SAVA
-
Matts insights taken wisely can be used as great trading reference here is by far one of the largest private investors I am familiar with in $SAVA.
-
$SAVA this baby is going to FLY
-
$SAVA EASY BUY AND HOLD!
-
$SAVA this is going to SOAR!
-
$SAVA Tomorrow should be a good day
-
$SAVA this is going to LAUNCH!
-
$SAVA just wait for the news
-
$SAVA this will still fly. Easy buy & hold.
-
Roche + Sangmo Therapeutics, not $SAVA, just need to put that to rest. Thursday AM investors update from Rick Barry - more about confidence in the home stretch than news that will send the stock up. Buy and hold tight for P3.
-
$SAVA - lots of calls today. Perhaps 80% more than puts. That should be interpreted as bullish and perhaps someone or many someone’s are in the know about something.
-
$SAVA - lots of calls today. Perhaps 80% more than puts. That should be interpreted as bullish and perhaps someone or many someone’s are in the know about something.
-
Cassava Sciences (NASDAQ:SAVA) Shares Down 3.8%
news.google.com • -
Cassava Sciences stock gains on pact with ex-CEO (NASDAQ:SAVA)
news.google.com • -
Cassava Sciences (NASDAQ:SAVA) Trading Up 10.8%
news.google.com • -
(SAVA) Technical Pivots with Risk Controls
news.google.com •